Starr International Company’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$3.36M Hold
1,528,139
16.91% 2
2023
Q2
$8.1M Hold
1,528,139
35.66% 2
2023
Q1
$9.47M Hold
1,528,139
46.46% 2
2022
Q4
$19.7M Hold
1,528,139
59.01% 1
2022
Q3
$35.3M Hold
1,528,139
73.55% 1
2022
Q2
$52M Hold
1,528,139
78.66% 1
2022
Q1
$133M Buy
1,528,139
+664,069
+77% +$39.8M 89.13% 1
2021
Q4
$44.2M Buy
+864,070
New +$55.2M 73.86% 1

Other funds holding CELU

Starr International Company's CELU Position: Q3 2023 in Review

Starr International Company held its Celularity (CELU) position steady in Q3 2023 at 1,528,139 shares worth $3.36M. The position accounts for 16.91% of the portfolio, ranked #2.

Starr International Company first reported a position in CELU in Q4 2021 and has held it in 8 quarters since. The position peaked at $133M in Q1 2022. 45 funds tracked by Wall St. Rank hold CELU as of Q3 2023.

  • Starr International Company held 1,528,139 shares of Celularity worth $3.36M as of Q3 2023.
  • Starr International Company left its Celularity share count unchanged in Q3 2023.
  • Celularity made up 16.91% of Starr International Company's portfolio in Q3 2023, its #2 holding.
  • Starr International Company first reported a position in Celularity in Q4 2021 and has held it in 8 quarters since.
  • Starr International Company's Celularity position peaked at $133M in Q1 2022.
  • 45 funds tracked by Wall St. Rank held Celularity as of Q3 2023.

Based on Starr International Company's 13F filing for Q3 2023, filed 14 Nov 2023.